Treatment Modification to Reduce Symptom Burden in Hemodialysis
NCT ID: NCT01775800
Last Updated: 2018-10-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2013-01-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anxiety and Symptom Burden in Hemodialysis Patients
NCT04143100
A Guided Meditation Program in Patients Undergoing Dialysis
NCT04155216
Impact of Different Dialysis on Sleep Apnea in Patients With Renal Failure
NCT00380848
Risk Factors and Application of Risk Management Strategies in Hemodialysis Patients Complicated With Heart Failure
NCT06959927
Symptom Management in Patients on Dialysis
NCT05515991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment modification
Patients in this arm will be treated to different targets of blood pressure, parathyroid hormone and serum phosphorus.
Treatment modification
Usual care
Patients will receive the usual hemodialysis care with no modifications
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment modification
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* transplant ineligible
Exclusion Criteria
* unable to answer questionnaires for any reason
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
The Rogosin Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathaniel Berman, M.D.
Role: PRINCIPAL_INVESTIGATOR
The Rogosin Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Rogosin Institute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Berman N, Reid MC, Teresi J, Eimicke JP, Adelman R. More with Less: A Trial of Reduced-Intensity Treatment in Transplant-Ineligible Hemodialysis Patients. J Palliat Med. 2016 May;19(5):503-8. doi: 10.1089/jpm.2015.0338.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1207012494
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.